It can be challenging to differentiate severe primary IGF-I deficiency from other conditions of short stature. In this micro learning, expert paediatric endocrinologists from PE CONNECT share their knowledge of identifying and treating SPIGFD in practice.

You'll learn how to recognise the typical presentation of SPIGFD and how a combination of clinical assessment and biochemical analysis of the GH-IGF-I axis can support your diagnosis of this rare condition.

After watching the video, take the assessment to earn your CME credit.

 

Clinical Takeaways

  • Severe primary IGF-I deficiency (SPIGFD) generally presents as classical Laron syndrome, but non-classical cases with mild or moderate phenotypes should also be considered
  • An endocrine investigation should be conducted to assess the GH-IGF-I axis to ensure appropriate diagnosis
  • Diagnosis of severe primary IGF-I deficiency requires severe short stature, low serum IGF-I and normal or increased growth hormone secretion, as well as lack of other pathology
  • An early and correct diagnosis is essential to allow children to achieve their full growth potential with appropriate treatment

 

This SPIGFD micro learning programme is endorsed by:

The MAGIC Foundation is a national nonprofit organization created to provide support services for the families of children afflicted with a wide variety of chronic and/or critical disorders, syndromes and diseases that affect a child's growth. Some of the diagnoses are quite common while others are very rare.

 

The Human Growth Foundation is a world leading nonprofit organization focused on children and adults with rare growth and bone conditions. We provide research, education, patient support, and advocacy to help improve the quality of life for those affected by these disorders. Our vision is that all people with rare growth or bone conditions have access to the best care possible.

Prof. Philippe Backeljauw has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Prof. Philippe Backeljauw is a consultant for Novo Nordisk, Novartis/Sandoz, Tolmar Pharmaceuticals, Ascendis Pharma, BioMarin Pharmaceutical, Cavalry Biosciences and Ipsen, and currently receives research support from Novo Nordisk, Novartis and Ipsen

Prof. Peter Bang has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Prof. Peter Bang is a consultant for Ipsen and Lilly

Programme summary
Share this programme
This educational programme is supported by an Independent Educational Grant from Ipsen
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Ipsen
Accreditation
EACCME-accredited
This course has been accredited by EACCME® for ECMEC®.
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
PE CONNECT

PE CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Ipsen.

Meet the experts Independent IME approved

Other programmes of interest

podcast Podcast

Episode

of

episode
  • clock 19 MIN
  • calendar Jul 2024

this xxx bayer
publication Publication
Oncology Rare diseases Endocrinology 
Acromegaly and Neuroendocrine Tumours Global Survey

Paper published in Advances in Therapy

Endorsed by
Wapo INCA
  • download Downloadable
    Resources
  • clock 15 MIN
  • calendar Aug 2023

Ipsen
video Video
Endocrinology Rare diseases 
Pituitary Updates from ECE & ENDO 2023

Prof. Maria Fleseriu provides 2023 conference data highlights

Experts
Prof. Maria Fleseriu
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Jul 2023

Brought to you by COR2ED Medical Affairs in collaboration with Ipsen.
podcast Podcast

Episode

2

of 2

episode
Rare diseases 
Primary Biliary Cholangitis Highlights from EASL 2023 – Episode 2

PBC Highlights from EASL 2023: Episode 2

Experts
Dr Emma Culver, Prof. Gideon Hirschfield, Ms Kath Houghton, Mr Robert Mitchell-Thain
  • download Downloadable
    Resources
  • clock 22 MIN
  • calendar Jun 2023

Ipsen
podcast Podcast

Episode

1

of 2

episode
Rare diseases 
Primary Biliary Cholangitis Highlights from EASL 2023 – Episode 1

PBC Highlights from EASL: Episode 1

Experts
Dr Emma Culver, Prof. Gideon Hirschfield, Ms Kath Houghton, Mr Robert Mitchell-Thain
  • download Downloadable
    Resources
  • clock 30 MIN
  • calendar Jun 2023

Ipsen

Episode

2

of 2

episode
Cardiology Endocrinology 
Managing Patients with Heart Disease – 2

Prevention and Management of Heart Disease in T2D Patients

Experts
Prof. Gilles Montalescot, Prof. Gaetano Maria De Ferrari, Prof. Peter. J. Grant, Prof. François Mach, Prof. Pepe Zamorano
  • download Downloadable
    Resources
  • clock 83 MIN
  • calendar Jan 2023

Educational programme supported by an Independent Educational Grant from Amgen